Actinium Pharmaceuticals (ATNM) Long-Term Debt Issuances (2010 - 2020)
Actinium Pharmaceuticals (ATNM) posted quarterly Long-Term Debt Issuances of $38000.0 for Q4 2020, up 52.0% year-over-year from $25000.0 in Q1 2020, and down 67.24% quarter-over-quarter from $116000.0 in Q3 2020.
Actinium Pharmaceuticals (ATNM) Long-Term Debt Issuances (2010 - 2020) Analysis & Trends
Actinium Pharmaceuticals (ATNM) has reported Long-Term Debt Issuances for 9 consecutive years, with $38000.0 the latest figure, recorded in Q4 2020.
- In Q4 2020, Long-Term Debt Issuances rose 52.0% year-over-year to $38000.0; the TTM figure through Dec 2020 stood at $381000.0 (up 53.01% YoY), while the FY2020 annual figure was $381000.0, up 53.01% from the prior year.
- Long-Term Debt Issuances fell to $38000.0 in Q4 2020 per ATNM's latest filing, from $116000.0 in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $116000.0 in Q3 2020 and bottomed at $25000.0 in Q4 2019.
- Historically, Long-Term Debt Issuances has averaged $81426.8 across 3 years, with a median of $87576.0 in 2016.
- Annual changes were most pronounced in 2016 — Long-Term Debt Issuances declined 9.17% — and 2020, when it surged 53.7%.
- Actinium Pharmaceuticals' Long-Term Debt Issuances stood at $89569.0 in 2016, then tumbled by 72.09% to $25000.0 in 2019, then surged by 52.0% to $38000.0 in 2020.
- Business Quant data shows ATNM's Long-Term Debt Issuances at $38000.0 in Q4 2020, $116000.0 in Q3 2020, and $114000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Actinium Pharmaceuticals | 35.01 Mn | 35.01 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 38,000.00 |
| Dec 31, 2020 | 38,000.00 |
| Sep 30, 2020 | 116,000.00 |
| Sep 30, 2020 | 116,000.00 |
| Jun 30, 2020 | 114,000.00 |
| Jun 30, 2020 | 114,000.00 |
| Mar 31, 2020 | 113,000.00 |
| Mar 31, 2020 | 113,000.00 |
| Dec 31, 2019 | 25,000.00 |
| Dec 31, 2019 | 25,000.00 |
| Sep 30, 2019 | 76,000.00 |
| Sep 30, 2019 | 76,000.00 |
| Jun 30, 2019 | 74,171.00 |
| Jun 30, 2019 | 74,171.00 |
| Mar 31, 2019 | 73,829.00 |
| Mar 31, 2019 | 73,829.00 |
| Sep 30, 2016 | 89,569.00 |
| Sep 30, 2016 | 89,569.00 |
| Jun 30, 2016 | 88,550.00 |
| Jun 30, 2016 | 88,550.00 |